Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 22.65% is in line with its 2-year average of 24.28%, near the low end of its 2-year range (22.65%–25.11%).
As of the fiscal period ended Tuesday, March 31, 2026. 5.83% below its 12-month average of 24.05%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
22.65%
GROSS MARGIN AVG TTM
24.05%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.83%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
59.09%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-61.67%
vs the sector median at left
Market Cap
$30.72B
Gross Margin
42.90%
TTM Avg
40.85%
3Y Avg
40.34%
5Y Avg
40.27%
Market Cap
$28.62B
Gross Margin
59.30%
TTM Avg
57.84%
3Y Avg
57.54%
5Y Avg
57.23%
Market Cap
$38.68B
Gross Margin
26.23%
TTM Avg
30.59%
3Y Avg
32.75%
5Y Avg
33.07%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $33.22B | 22.65% | 24.05% | N/A | N/A |
| Zoetis Inc. (ZTS)vs › | $32.40B | 70.75% | 69.79% | 68.91% | 68.46% |
| DexCom, Inc. (DXCM)vs › | $32.20B | 62.79% | 60.23% | 62.09% | 63.91% |
| Centene Corp. (CNC)vs › | $30.74B | 16.13% | 11.28% | 11.33% | 11.71% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 42.90% | 40.85% | 40.34% | 40.27% |
| ResMed Inc. (RMD)vs › | $30.60B | 61.69% | 58.02% | 57.09% | 57.33% |
| Biogen Inc. (BIIB)vs › | $29.99B | 70.47% | 73.30% | 74.61% | 77.63% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.62B | 59.30% | 57.84% | 57.54% | 57.23% |
| IQVIA Holdings Inc. (IQV)vs › | $38.68B | 26.23% | 30.59% | 32.75% | 33.07% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $27.44B | 81.77% | 83.69% | 83.53% | 83.62% |
Gross Margin
22.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 22.65% |
| 2025-12-31 | 24.58% |
| 2025-09-30 | 23.87% |
| 2025-06-30 | 25.11% |
| 2025-03-28 | 24.82% |
| 2024-09-30 | 24.80% |
| 2024-06-30 | 24.16% |
